Gene expression profile changes correlated with lymph node metastasis in oral squamous cell carcinoma

Odontology

Volumn 96, Issue 1, 2008, Pages 38-43

  Kashiwazaki, Haruhiko ^a   Hassan, Nur Mohammad Monsur ^a   Hamada, Jun Ichi ^a   Moriuchi, Tetsuya ^a   Yamazaki, Yutaka ^a   Tei, Kanchu ^a   Totsuka, Yasunori ^a   Inoue, Nobuo ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Biomarkers; cDNA array; Gene expression profiling; Lymphnode metastasis; Oral squamous cell carcinoma

Indexed keywords

CELL ADHESION MOLECULE; MATRILYSIN; STROMELYSIN; TUMOR MARKER;

ARTICLE; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LYMPH NODE METASTASIS; MOUTH TUMOR; NEOVASCULARIZATION (PATHOLOGY); SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; CELL ADHESION MOLECULES; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHATIC METASTASIS; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 7; MOUTH NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 48449105484     PISSN: 16181247     EISSN: 16181255     Source Type: Journal    
DOI: 10.1007/s10266-008-0084-1     Document Type: Article

References (26)

1. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 1993;54:594-606.
2. Kalnins IK, Leonard AG, Sako K, Razack MS, Shedol DP. Correlation between prognosis and degree of lymph node involvement in carcinoma of the oral cavity. Am J Surg 1977;134:450-454.
3. Yamazaki Y, Chiba I, Hirai A, Satoh C, Sakakibara N, Notani K, Iizuka T, Totsuka Y. Clinical value of genetically diagnosed lymph node micrometastasis for patients with oral squamous cell carcinoma. Head Neck 2005;27:676-681.
4. Yao L, Iwai M, Furuta I. Correlation of bcl2 and p53 expression with the clinico pathological features in tongue squamous cell carcinomas. Oral Oncol 1999;35:56-62.
5. DeRisi J, Penland L, Brown PO, Bittner ML, Meltzer PS, Ray M, Chen Y, Su YA, Trent JM. Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nat Genet 1996;14:457-460.
6. Liotta L, Petricoin E. Molecular profiling of human cancer. Nat Rev Genet 2000;1:48-56.
7. Teramoto K, Tada M, Tamoto E, Abe M, Kawakami A, Komuro K, Matsunaga A, Shindoh G, Takada M, Murakawa K, Kanai M, Kobayashi N, Fujiwara Y, Nishimura N, Shirata K, Takahishi T, Ishizu A, Ikeda H, Hamada J, Kondo S, Katoh H, Moriuchi T, Yoshiki T. Prediction of lymphatic invasion/ lymph node metastasis, recurrence, and survival in patients with gastric cancer by cDNA array-based expression profiling. J Surg Re s 2005;124(2):225-236.
8. Komuro K, Tada M, Tamoto E, Kawakami A, Matsunaga A, Teramoto K, Shindoh G, Takada M, Murakawa K, Kanai M, Kobayashi N, Fujiwara Y, Nishimura N, Hamada J, Ishizu A, Ikeda H, Kondo S, Katoh H, Moriuchi T, Yoshiki T. Right-and left-sided colorectal cancers display distinct expression profiles and the anatomical stratification allows a high accuracy prediction of lymph node metastasis. J Surg Res 2005;124(2):216-224.
9. Murakawa K, Tada M, Takada M, Tamoto E, Shindoh G, Teramoto K, Matsunaga A, Komuro K, Kanai M, Kawakami A, Fujiwara Y, Kobayashi N, Shirata K, Nishimura N, Okushiba S, Kondo S, Hamada J, Katoh H, Yoshiki T, Moriuchi T. Prediction of lymph node metastasis and perineural invasion of biliary tract cancer by selected features from cDNA array data. J Surg Res 2004;122(2):184-194.
10. Takada M, Tada M, Tamoto E, Kawakami A, Murakawa K, Shindoh G, Teramoto K, Matsunaga A, Komuro K, Kanai M, Fujiwara Y, Shirata K, Nishimura N, Miyamoto M, Okushiba S, Kondo S, Hamada J, Katoh H, Yoshiki T, Moriuchi T. Prediction of lymph node metastasis by analysis of gene expression profiles in non-small cell lung cancer. J Surg Res 2004;122(1):61-69.
11. Tamoto E, Tada M, Murakawa K, Takada M, Shindo G, Teramoto K, Matsunaga A, Komuro K, Kanai M, Kawakami A, Fujiwara Y, Kobayashi N, Shirata K, Nishimura N, Okushiba S, Kondo S, Hamada J, Yoshiki T, Moriuchi T, Katoh H. Gene-expression profile changes correlated with tumor progression and lymph node metastasis in esophageal cancer. Clin Cancer Res 2004;10(11):3629-3638.
12. Benjamini Y, Hochberg Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc Ser B 1995;57:289-300.
13. Murai M, Shen X, Huang L, Carpenter WM, Lin CS, Silvenman S, Regezi J, Kramer RH. Overexpression of c-met in oral SCC promotes hepatocyte growth factor-induced disruption of cadherin junctions and invasion. Int J Oncol 2004;25(4):831-840.
14. Sedivy R, Beck-Mannagetta J, Harverkampf C, Battistutti W, Hönigschnabl S. Expression of vascular endothelial growth factor-C correlates with the lymphatic microvessel density and the nodal status in oral squamous cell cancer. J Oral Pathol Med 2003;32(8):455-460.
15. Lai SY, Childs EE, Xi S, Coppelli FM, Gooding WE, Wells A, Ferris RL, Grandis JR. Erythropoietin-mediated activation of JAK-STAT signaling contributes to cellular invasion in head and neck squamous cell carcinoma. Oncogene 2005;24:4442-4449.
16. Scherberich A, Tucker RP, Degen M, Brown-Luedi M, Andres A-C, Chiquet-Ehrismann R. Tenascin-W is found in malignant mammary tumors, promotes alpha8 integrin-dependent motility and requires p38 MAPK activity for BMP-2 and TNF-alpha induced expression in vitro. Oncogene 2005;24:1525-1532.
17. Deng G, Curriden SA, Wang S, Rosenberg S, Loskutoff DJ. Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release. J Cell Biol 1996;134:1563-1571.
18. Olofsson B, Korpelainen E, Pepper MS, Mandriota SJ, Aase K, Kumar V, Gunji Y, Jeltsch MM, Shibuya M, Alitalo K, Eriksson U. Vascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cells. Proc Natl Acad Sci U S A 1998;95:11709-11714.
19. Kusukawa J, Sasaguri Y, Morimatsu M, Kameyama T. Expression of matrix metalloproteinase-3 in stage I and II squamous cell carcinoma of the oral cavity. J Oral Maxillofac Surg 1995;53(5):530-534.
20. Tanioka Y, Yoshida T, Yagawa T, Saiki Y, Takeo S, Harada T, et al. Matrix metalloproteinase-7 and matrix metalloproteinase-9 are associated with unfavourable prognosis in superficial oesophageal cancer. Br J Cancer 2003;89:2116-2121.
21. Yamashita K, Mori M, Shiraishi T, Shibuta K, Sugimachi K. Clinical significance of matrix metalloproteinase-7 expression in esophageal carcinoma. Clin Cancer Res 2000;6(3):1169-1174.
22. Nagata M, Fujita H, Ida H, Hoshina H, Inoue T, Seki Y, Ohnishi M, Ohyama T, Shingaki S, Kaji M, Saku T, Takagi R. Identification of potential biomarkers of lymph node metastasis in oral squamous cell carcinoma by cDNA microarray analysis. Int J Cancer 2003;106:683-689.
23. Watabe T, Yoshida K, Shindou M, Kaya M, Fujikwa K, Sato H, Seiki M, Ishii S, Fujinaga K. The Ets-1 and Ets-2 transcription factors activate the promoters for invasion-associated urokinase and collagenase genes in response to epidermal growth factor. Int J Cancer 1998;77:128-137.
24. Peters H, Neubuser A, Kratochwil K, Balling R. Pax9-deficient mice lack pharyngeal pouch derivatives and teeth and exhibit craniofacial and limb abnormalities. Genes Dev 1998;12:2735-2747.
25. Peters H, Schuster G, Neubuser A, Richter T, Hofler H, Balling R. Isolation of the Pax9 cDNA from adult human oesophagus. Mamm Genome 1997;8:62-64.
26. Gerber J-K, Richter T, Kremmer E, Adamski J, Höfler H, Balling R, Peters H. Progressive loss of PAX9 expression correlates with increasing malignancy of dysplastic and cancerous epithelium of the human oesophagus. J Pathol 2002;197(3):293-297.